Treatment of blepharospasm and Meige ’s syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice

ConclusionThe treatment of blepharospasm and Meige ’s syndrome with onabotulinumtoxinA and abobotulinumtoxinA is safe and effective, also over a long observation period of up to 29 years.
Source: Journal of Neurology - Category: Neurology Source Type: research